APA (7th ed.) Citation

Ronnacker, J., Muller, P. J., Mikesch, J., Zukunft, S., Weinbergerová, B., Šrámek, J., . . . Hanoun, M. (2025). Gemtuzumab ozogamicin in first-line treatment of CBF-AML: Insights from a retrospective multi-center analysis : acute myeloid leukemia. Leukemia, 39(9), . https://doi.org/10.1038/s41375-025-02700-9

Chicago Style (17th ed.) Citation

Ronnacker, Julian, et al. "Gemtuzumab Ozogamicin in First-line Treatment of CBF-AML: Insights from a Retrospective Multi-center Analysis : Acute Myeloid Leukemia." Leukemia 39, no. 9 (2025). https://doi.org/10.1038/s41375-025-02700-9.

MLA (9th ed.) Citation

Ronnacker, Julian, et al. "Gemtuzumab Ozogamicin in First-line Treatment of CBF-AML: Insights from a Retrospective Multi-center Analysis : Acute Myeloid Leukemia." Leukemia, vol. 39, no. 9, 2025, https://doi.org/10.1038/s41375-025-02700-9.